Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: A Study to Evaluate the Real-world Experience and Satisfaction Associated With Ofatumumab

View source ↗

Summary

This entry reports on a real-world study evaluating patient experience and satisfaction with ofatumumab for multiple sclerosis. The study is currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Kesimpta (ofatumumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Multiple Sclerosis | Status: ACTIVE_NOT_RECRUITING